Showing 541-550 of 2652 results for "".
Two More Eye Drop Brands Recalled
https://modernod.com/articles/significant-findings/two-more-eye-drop-brands-recalled/37727/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPDUFA Date Approaches for Apellis Drug
https://modernod.com/articles/significant-findings/pdufa-date-approaches-for-apellis-drug/37722/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatTime for a New Imaging System?
https://modernod.com/topics/business/time-for-a-new-imaging-system/38439/Should you purchase a new device outright, lease it, or opt for a subscription–based deal?How Genetics Factor Into Corneal Disease
https://modernod.com/mod-issues/2022-mar/how-genetics-factor-into-corneal-disease/38392/Genetic testing can assess a patient’s risk of developing keratoconus and inform your treatment plan.Kids in Contact Lenses
https://modernod.com/topics/contact-lenses/kids-in-contact-lenses/38270/Why this option may be appropriate for some of your young patients.What’s New in Contact Lenses
https://modernod.com/topics/contact-lenses/whats-new-in-contact-lenses-1/38238/A look at developments over the past year.50. IRPL Technology with I-MED Pharma: Part Two
https://modernod.com/podcasts/four-eyes/50-irpl-technology-with-i-med-pharma-part-two/37000/This episode is sponsored by I-MED PHARMA.I-MED Pharma is a Canadian company specializing in dry eye diagnosis and management since 1989. I-MED Pharma provides innovative ocular surface disease solutions to Canadian optometrists, ophthalmologists, and the global eye care community. The company has aEffective Leadership Through Turbulent Times
https://modernod.com/topics/business/effective-leadership-through-turbulent-times/38203/Be aware of your environment and tune in to the needs of your team.Casting a Light on Race and Racism in Optometry
https://modernod.com/topics/business/casting-a-light-on-race-and-racism-in-optometry/38202/You may not see it or experience it, but it occurs every day, and we all need to work toward ending it.Answering the Call of Presbyopic Patients
https://modernod.com/topics/technology/answering-the-call-of-presbyopic-patients/38187/The number of patients with this age-related condition is on the rise; are you prepared to meet their needs?
